Clinical Trials Logo
  1. Home
  2. Rotavirus Infection
  3. NCT01511133

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

Rotavirus Infection Clinical Trial

Official title:
Blinded Retrospective Laboratory Evaluations to Assess the Serologic Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in the Stool of Infants Aged 6 to 12 Weeks Following Administration of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus Vaccine (444563)

Clinical Trial Summary

This study aims to test the clinical samples (stool and serum) previously collected during clinical development of HRV vaccine, to identify if there is any evidence of PCV-1 replication and/or immune response to the PCV-1 in vaccinated infants.

Clinical Trial Description

Serum and stool samples collected from 4 clinical trials previously conducted for HRV vaccine (Rotarix™) are used in this study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01511133
Study type Observational
Source GlaxoSmithKline
Contact
Status Completed
Phase N/A
Start date April 2010
Completion date June 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT03207750 - This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Phase 3
Completed NCT00895492 - Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile N/A
Completed NCT01266850 - Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules Phase 4
Completed NCT02992197 - The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity Phase 4
Completed NCT00981877 - Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children N/A
Completed NCT05032391 - Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization Phase 3
Active, not recruiting NCT02662543 - The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines N/A
Completed NCT00302640 - Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children Phase 2/Phase 3
Active, not recruiting NCT04626856 - Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection Phase 1
Completed NCT01764256 - A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine Phase 1
Completed NCT00880698 - Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers Phase 2
Completed NCT01328925 - Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children Phase 2
Completed NCT00683982 - Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus N/A